In conclusion, our study provides intensive evidence in vitro and in vivo to demonstrate that anti-CD31-ORI-NPs targeting endothelial cells in lung tissues not only enhanced the anti-inflammatory and antioxidant effects of ORI but also prevented neutrophil migration and infiltration to alleviate ALI/ARDS with low cytotoxicity. This evidence concerns the gene PECAM1 and acute respiratory distress syndrome.